BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1980 related articles for article (PubMed ID: 17527079)

  • 21. Gallbladder polyps in primary sclerosing cholangitis: not so benign.
    Karlsen TH; Schrumpf E; Boberg KM
    Curr Opin Gastroenterol; 2008 May; 24(3):395-9. PubMed ID: 18408471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
    Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
    J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of primary sclerosing cholangitis.
    Björnsson E
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
    Layfield LJ; Cramer H
    Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
    Weismüller TJ; Wedemeyer J; Kubicka S; Strassburg CP; Manns MP
    J Hepatol; 2008; 48 Suppl 1():S38-57. PubMed ID: 18304683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
    Tischendorf JJ; Meier PN; Strassburg CP; Klempnauer J; Hecker H; Manns MP; Krüger M
    Scand J Gastroenterol; 2006 Oct; 41(10):1227-34. PubMed ID: 16990210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation.
    Nashan B; Schlitt HJ; Tusch G; Oldhafer KJ; Ringe B; Wagner S; Pichlmayr R
    Hepatology; 1996 May; 23(5):1105-11. PubMed ID: 8621141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
    Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
    Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
    Ehlken H; Schramm C
    Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High lifetime risk of cancer in primary sclerosing cholangitis.
    Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
    J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary sclerosing cholangitis].
    Boonstra K; Ponsioen CI; Rauws EA; Beuers U
    Ned Tijdschr Geneeskd; 2010; 154():A1476. PubMed ID: 20619015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union.
    Jung YS; Lee KJ; Kim H; Kim WH; Kim IG; Yoo BM; Kim JH; Kim MW
    Hepatogastroenterology; 2004; 51(58):946-9. PubMed ID: 15239220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
    Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
    Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
    Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
    Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary sclerosing cholangitis: role of extrahepatic biliary resection.
    Pawlik TM; Olbrecht VA; Pitt HA; Gleisner AL; Choti MA; Schulick RD; Cameron JL
    J Am Coll Surg; 2008 May; 206(5):822-30; discussion 830-2. PubMed ID: 18471705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.
    Rudolph G; Gotthardt D; Kloeters-Plachky P; Rost D; Kulaksiz H; Stiehl A
    J Hepatol; 2010 Aug; 53(2):313-7. PubMed ID: 20472317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.
    Majeed A; Castedal M; Arnelo U; Söderdahl G; Bergquist A; Said K
    Scand J Gastroenterol; 2018 Jan; 53(1):56-63. PubMed ID: 28990806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenocarcinoma of gallbladder: an immunohistochemical profile and comparison with cholangiocarcinoma.
    Hughes NR; Bhathal PS
    J Clin Pathol; 2013 Mar; 66(3):212-7. PubMed ID: 23268317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 99.